Recent advances in brain imaging have improved understanding of acute and chronic pain, but have led to an increased in the demand to use this data for insurance and medical legal cases. However, a task force is advising against the use of brain imaging as a “lie detector” test for chronic pain.
Hospitals with more nurses on staff and better nurse-patient communication tend to receive higher scores on patients’ satisfaction with pain management, according to new research.
Data presented during PAINWeek show that the rate of drug misuse among teenagers has dropped dramatically.
The FDA has approved the first 2D digital mammography system that lets patients adjust the level of compression applied to their breast during the imaging procedure.
A new draft report from the Institute for Clinical and Economic Review (ICER) indicates that cognitive and mind-body therapies may be valuable additions to usual care for chronic back and neck pain, but that more evidence is needed to understand the cost-effectiveness implications for both conditions.
Medicinal cannabis has become increasingly accepted in the United States and is commonly used for pain management. Despite its growing popularity as a treatment, there is little evidence available about the harms and benefits of cannabis utilization.
Study finds there is little evidence to suggest that an oxycodone HCI extended-release tablets nonformulary restriction has a direct effect on patient enrollment behavior.
Prescription opioids, intended for post-surgery utilization, often go unused and undisposed, leading to the nonmedical use of opioids that could have harmful consequences.
The most common type of pain among older adults is back pain, yet its impact on the everyday lives of individuals is often not considered. The physical, psychological, and social influence of activity restrictive back pain need to be measured when evaluating treatment for back pain.
Recently, there have been efforts to reduce opioid use instead of increasing pain relief, and authors of a JAMA Viewpoint article argue that the movement to eliminate opioids for treating chronic pain is unnecessary.
Patients with long-term conditions are more inclined to choose services with person-centered care attributes, according to recent research.
In response to a request from the FDA, the National Academies of Sciences, Engineering, and Medicine has issued a report outlining the current body of research on chronic pain and opioid use disorder, including recommendations on what steps the regulatory agency can take in response to the ongoing epidemic.
Patients with chronic obstructive pulmonary disease (COPD) often experience chronic pain symptoms, including low physical activity, depression, and hyperinflation, that impact their everyday lives.
A new study indicates that adults with mental health disorders receive more than 51% of all opioids prescribed in the United States each year, further illustrating the complex relationship between mental health and substance abuse.
This study identified populations with non-cancer chronic pain to determine which patients may be more likely to receive an opioid prescription in an outpatient setting.
A new study in JAMA has found that patient-reported pain satisfaction scores on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) surveys are not associated with rates of opioid prescribing after surgery.
In primary care, nurse practitioners and physician assistants do not necessarily order more ancillary services, or more costly services among alternatives, than physicians.
Palliative care can help alleviate the suffering and symptoms that go along with serious disease, making it an important component when caring for complex, high-need patients, said Allison Silvers, vice president of payment and policy at the Center to Advance Palliative Care.
Two surveys, one each for patients and providers, reveal gaps between patient confidence to manage disease or pain and what they'd like to see from their physicians.
This study describes the patient characteristics and healthcare utilization of a chronic pain population within an integrated healthcare system in northern California.
The collaboration between Purdue Pharma and the Virginia Department of Health comes about 2 months after Governor Terry McAuliffe declared the state’s opioid addiction crisis a public health emergency.
A review of our peer-reviewed research in the healthcare and mainstream press.
